Resflam 300/20 mg/ml Solution for Injection for Cattle
Resflam 300/20 mg/ml Solution for Injection for Cattle
Authorised
- Flunixin meglumine
- Oxytetracycline dihydrate
Product identification
Medicine name:
Resflam 300/20 mg/ml Solution for Injection for Cattle
Active substance:
- Flunixin meglumine
- Oxytetracycline dihydrate
Target species:
-
Cattle
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Flunixin meglumine33.18/milligram(s)1.00millilitre(s)
-
Oxytetracycline dihydrate323.52/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cattle
-
Meat and offal28day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01AA56
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Ireland
Package description:
- Supplied in 100 ml type I/II, amber glass vial, sealed with bromobutyl rubber bung and aluminium cap.
- Supplied in 50 ml type I/II, amber glass vial, sealed with bromobutyl rubber bung and aluminium cap.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Informed consent application (Article 13c of Directive No 2001/82/EC)
Marketing authorisation holder:
- Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Norbrook Laboratories Limited
- Norbrook Manufacturing Limited
- Norbrook Laboratories Limited
Responsible authority:
- Health Products Regulatory Authority
Authorisation number:
- VPA22664/085/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 26/08/2024